MAP3K15 variant found to be a potential target for managing diabetes

Research scientist using digital tablet to browse internet and find biochemistry discovery. Female chemist working with device to create pharmaceutical cure, microbiology experiment.

A team of researchers at AstraZeneca, working with colleagues from the University of Mexico and the University of Oxford, has found that a protein tied to the MAP3K15 gene variant may represent a potential target for managing both type I and type II diabetes. The paper is published in the journal Science Advances.

Researcher shows how a common fungus eliminates toxic mercury from soil and water

Previous article

Job seekers like companies that say Black Lives Matter

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations